Dr. Peter Block highlights the ABSORB IV trial which examined a polymeric everolimus-eluting bioresorbable scaffold in an expanded patient population using optimized technique.

Keywords: Transcatheter Cardiovascular Therapeutics, TCT18

< Back to Listings